Akanocure Pharmaceuticals, Inc.  logo — Where novel chemistry and innovative drug design come togeth...

Akanocure Pharmaceuticals, Inc.

Where novel chemistry and innovative drug design come together to tackle orphan and unmet needs in cancer.

Founded 2015 United States West Lafayette, United States 3 employees Grant Total: $1.99M Health Care, Health and Wellness +1

General Information

Company Name Akanocure Pharmaceuticals, Inc.
Founded Year 2015
Location United States West Lafayette, United States
Founders / Decision Makers
Team member Team member
Employees 3
Industries Health Care, Health and Wellness, Pharmaceutical
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Akanocure Pharmaceuticals, Inc. . To contact Akanocure Pharmaceuticals, Inc. , visit akanocure.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Akanocure Pharmaceuticals, Inc.

Akanocure Pharmaceuticals, Inc. is a pharmaceutical company founded in 2015 in the United States that focuses on addressing orphan and unmet needs in cancer treatment. The company's slogan, "Where novel chemistry and innovative drug design come together to tackle orphan and unmet needs in cancer," reflects its dedication to pioneering drug development. Akanocure's unique approach combines a passion for drug design with an innovative chemistry platform, aiming to create novel small molecules that can positively impact the lives of cancer patients. Their primary mission is to discover therapeutic approaches that can effectively block metastatic processes, which are responsible for 90% of cancer deaths. Akanocure Pharmaceuticals, Inc. has successfully integrated advanced chemical methodologies with classic drug discovery expertise, fostering a company culture driven by collaboration and partnership. By bringing together a team of experts with industry leaders, academia, and government, Akanocure is actively developing groundbreaking drugs that have the potential to make a significant difference in the lives of cancer patients. Their most recent investment of $5.00K came in the form of a grant from First Flight Venture Center on 10 August 2022, underlining the recognition and support they have garnered from the investment community. With a clear vision and strong industry connections, Akanocure Pharmaceuticals, Inc. is a promising player in the Health Care and Pharmaceutical sectors, poised to make a meaningful impact in the field of oncology.

Taxonomy: drug development, oncology, cancer research, metastasis prevention, novel drug design, chemistry platform, orphan diseases, unmet medical needs, small molecule therapeutics, chemical methodologies, collaborative partnerships, biopharmaceutical industry, medical innovation, cancer treatment

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $5.00K 1
First Flight Venture Center
10 Aug 2022
Grant $256.00K 1
National Science Foundation
27 Jan 2021
Grant $100.00K 1
Elevate Ventures
01 Jan 2021
Grant $800.00K 1
National Science Foundation
18 Mar 2020
Grant $50.00K -
01 Jul 2018
Grant $225.00K 1
National Science Foundation
01 Jan 2018
Pre Seed Round $50.00K 1
Purdue Ag-celerator
22 May 2017
Pre Seed Round $500.00K 2
Elevate Ventures, Purdue Foundry
15 Jun 2015

Akanocure Pharmaceuticals, Inc. Alternatives & Competitors

View All Alternatives
Akanocure Pharmaceuticals, Inc. vs
OncoSpherix
OncoSpherix United States

Advanced drugs for advanced cancers

Grant
5 employees
Health Care, Pharmaceutical
Akanocure Pharmaceuticals, Inc. vs

SelectX Pharmaceuticals is a biopharmaceutical company that focuses on the discovery and development...

Series B
6 employees
Biotechnology, Health Care
Akanocure Pharmaceuticals, Inc. vs

Addressing urgent unmet medical needs through deeper science, true originality, and rich experience....

Series B
69 employees
Biopharma, Biotechnology

FAQ About Akanocure Pharmaceuticals, Inc.

Where novel chemistry and innovative drug design come together to tackle orphan and unmet needs in cancer.
Akanocure Pharmaceuticals, Inc. was founded in 2015.
Akanocure Pharmaceuticals, Inc. is headquartered in West Lafayette, United States.
Akanocure Pharmaceuticals, Inc. operates in Health Care, Health and Wellness and Pharmaceutical. Its work centres on drug development, oncology, cancer research and metastasis prevention.
Akanocure Pharmaceuticals, Inc. has approximately 3 employees.
Akanocure Pharmaceuticals, Inc. has completed 8 funding rounds, raising a total of $1.99M. The latest funding stage is Grant.
Top alternatives and competitors to Akanocure Pharmaceuticals, Inc. include OncoSpherix, SelectX Pharmaceuticals, BlossomHill Therapeutics, Inc., Probmet Therapeutics, Senex Biotechnology. Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Akanocure Pharmaceuticals, Inc. and OncoSpherix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Akanocure Pharmaceuticals, Inc. , https://bouncewatch.com/company/akanocure-pharmaceuticals-inc, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes